-
Something wrong with this record ?
Clinical application of bladder MRI and the Vesical Imaging-Reporting and Data System
V. Panebianco, A. Briganti, TN. Boellaard, J. Catto, E. Comperat, J. Efstathiou, AG. van der Heijden, G. Giannarini, R. Girometti, L. Mertens, M. Takeuchi, VF. Muglia, Y. Narumi, G. Novara, M. Pecoraro, M. Roupret, F. Sanguedolce, D. Santini, SF....
Language English Country England, Great Britain
Document type Journal Article, Review
NLK
ProQuest Central
from 2009-04-01 to 1 year ago
Health & Medicine (ProQuest)
from 2009-04-01 to 1 year ago
- MeSH
- Consensus MeSH
- Humans MeSH
- Magnetic Resonance Imaging methods MeSH
- Urinary Bladder * diagnostic imaging MeSH
- Urinary Bladder Neoplasms * diagnostic imaging MeSH
- Retrospective Studies MeSH
- Research Design MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
Diagnostic work-up and risk stratification in patients with bladder cancer before and after treatment must be refined to optimize management and improve outcomes. MRI has been suggested as a non-invasive technique for bladder cancer staging and assessment of response to systemic therapy. The Vesical Imaging-Reporting And Data System (VI-RADS) was developed to standardize bladder MRI image acquisition, interpretation and reporting and enables accurate prediction of muscle-wall invasion of bladder cancer. MRI is available in many centres but is not yet recommended as a first-line test for bladder cancer owing to a lack of high-quality evidence. Consensus-based evidence on the use of MRI-VI-RADS for bladder cancer care is needed to serve as a benchmark for formulating guidelines and research agendas until further evidence from randomized trials becomes available.
Academic Urology Unit University of Sheffield Sheffield UK
Department of Healthcare Tachibana University Kyoto Japan
Department of Medical Surgical and Experimental Sciences University of Sassari Sassari Italy
Department of Medical Surgical Sciences and Biotechnologies Sapienza University Latina Italy
Department of Radiation Oncology Massachusetts General Hospital Harvard Medical School Boston MA USA
Department of Radiological Sciences Oncology and Pathology Sapienza University of Rome Rome Italy
Department of Radiology and Nuclear Medicine Radboudumc Nijmegen The Netherlands
Department of Radiology Memorial Sloan Kettering Cancer Center New York NY USA
Department of Radiology Netherlands Cancer Institute Amsterdam The Netherlands
Department of Radiology Radiolonet Tokai Nagoya Japan
Department of Surgery Oncology and Gastroenterology Urology Clinic University of Padua Padua Italy
Department of Surgical Oncology Netherlands Cancer Institute Amsterdam The Netherlands
Department of Urology Fundació Puigvert Autonomous University of Barcelona Barcelona Spain
Department of Urology Radboud University Medical Center Nijmegen The Netherlands
Department of Urology Sorbonne University AP HP Pitié Salpétrière Hospital Paris France
Division of Medical Oncology A Policlinico Umberto 1 Rome Italy
Institute of Radiology Academic Medical Centre Santa Maria della Misericordia Udine Italy
IRCCS Regina Elena National Cancer Institute Department of Urology Rome Italy
Urology Unit Academic Medical Centre Santa Maria della Misericordia Udine Italy
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24014503
- 003
- CZ-PrNML
- 005
- 20240905134225.0
- 007
- ta
- 008
- 240725s2024 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/s41585-023-00830-2 $2 doi
- 035 __
- $a (PubMed)38036666
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Panebianco, Valeria $u Department of Radiological Sciences, Oncology and Pathology, Sapienza University of Rome, Rome, Italy. valeria.panebianco@uniroma1.it $1 https://orcid.org/000000018466918X
- 245 10
- $a Clinical application of bladder MRI and the Vesical Imaging-Reporting and Data System / $c V. Panebianco, A. Briganti, TN. Boellaard, J. Catto, E. Comperat, J. Efstathiou, AG. van der Heijden, G. Giannarini, R. Girometti, L. Mertens, M. Takeuchi, VF. Muglia, Y. Narumi, G. Novara, M. Pecoraro, M. Roupret, F. Sanguedolce, D. Santini, SF. Shariat, G. Simone, HA. Vargas, S. Woo, J. Barentsz, JA. Witjes
- 520 9_
- $a Diagnostic work-up and risk stratification in patients with bladder cancer before and after treatment must be refined to optimize management and improve outcomes. MRI has been suggested as a non-invasive technique for bladder cancer staging and assessment of response to systemic therapy. The Vesical Imaging-Reporting And Data System (VI-RADS) was developed to standardize bladder MRI image acquisition, interpretation and reporting and enables accurate prediction of muscle-wall invasion of bladder cancer. MRI is available in many centres but is not yet recommended as a first-line test for bladder cancer owing to a lack of high-quality evidence. Consensus-based evidence on the use of MRI-VI-RADS for bladder cancer care is needed to serve as a benchmark for formulating guidelines and research agendas until further evidence from randomized trials becomes available.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a močový měchýř $x diagnostické zobrazování $7 D001743
- 650 _2
- $a magnetická rezonanční tomografie $x metody $7 D008279
- 650 12
- $a nádory močového měchýře $x diagnostické zobrazování $7 D001749
- 650 _2
- $a výzkumný projekt $7 D012107
- 650 _2
- $a konsensus $7 D032921
- 650 _2
- $a retrospektivní studie $7 D012189
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Briganti, Alberto $u Unit of Urology/Division of Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy
- 700 1_
- $a Boellaard, Thierry N $u Department of Radiology, Netherlands Cancer Institute, Amsterdam, The Netherlands
- 700 1_
- $a Catto, James $u Academic Urology Unit, University of Sheffield, Sheffield, UK
- 700 1_
- $a Comperat, Eva $u Department of Pathology, Sorbonne University, Assistance Publique-Hôpitaux de Paris, Hopital Tenon, Paris, France
- 700 1_
- $a Efstathiou, Jason $u Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA $1 https://orcid.org/0000000309960350
- 700 1_
- $a van der Heijden, Antoine G $u Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands $1 https://orcid.org/0000000288398601
- 700 1_
- $a Giannarini, Gianluca $u Urology Unit, Academic Medical Centre "Santa Maria della Misericordia", Udine, Italy $1 https://orcid.org/000000026995246X
- 700 1_
- $a Girometti, Rossano $u Institute of Radiology, Academic Medical Centre "Santa Maria della Misericordia", Udine, Italy
- 700 1_
- $a Mertens, Laura $u Department of Surgical Oncology (Urology), Netherlands Cancer Institute, Amsterdam, The Netherlands
- 700 1_
- $a Takeuchi, Mitsuru $u Department of Radiology, Radiolonet Tokai, Nagoya, Japan
- 700 1_
- $a Muglia, Valdair F $u Department of Medical Images, Radiation Therapy and Oncohematology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil $1 https://orcid.org/0000000247000599
- 700 1_
- $a Narumi, Yoshifumi $u Department of Healthcare, Tachibana University, Kyoto, Japan
- 700 1_
- $a Novara, Giacomo $u Department of Surgery, Oncology, and Gastroenterology - Urology Clinic, University of Padua, Padua, Italy $1 https://orcid.org/0000000346935058
- 700 1_
- $a Pecoraro, Martina $u Department of Radiological Sciences, Oncology and Pathology, Sapienza University of Rome, Rome, Italy
- 700 1_
- $a Roupret, Morgan $u Department of Urology, Sorbonne University, AP-HP, Pitié Salpétrière Hospital, Paris, France
- 700 1_
- $a Sanguedolce, Francesco $u Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Barcelona, Spain $u Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy $1 https://orcid.org/0000000252427060
- 700 1_
- $a Santini, Daniele $u Division of Medical Oncology A, Policlinico Umberto I, Rome, Italy $u Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University, Latina, Italy
- 700 1_
- $a Shariat, Shahrokh F $u Department of Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic $u Department of Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria
- 700 1_
- $a Simone, Giuseppe $u IRCCS "Regina Elena" National Cancer Institute, Department of Urology, Rome, Italy $1 https://orcid.org/0000000248689025
- 700 1_
- $a Vargas, Hebert A $u Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
- 700 1_
- $a Woo, Sungmin $u Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
- 700 1_
- $a Barentsz, Jelle $u Department of Radiology and Nuclear Medicine, Radboudumc, Nijmegen, The Netherlands
- 700 1_
- $a Witjes, J Alfred $u Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands
- 773 0_
- $w MED00184385 $t Nature reviews. Urology $x 1759-4820 $g Roč. 21, č. 4 (2024), s. 243-251
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38036666 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240725 $b ABA008
- 991 __
- $a 20240905134219 $b ABA008
- 999 __
- $a ok $b bmc $g 2143951 $s 1226369
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 21 $c 4 $d 243-251 $e 20231130 $i 1759-4820 $m Nature reviews. Urology $n Nat Rev Urol $x MED00184385
- LZP __
- $a Pubmed-20240725